目次

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 BRIC Pharmaceuticals
2.1. Industry Outlook

3 Pharmaceuticals in Brazil
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Pharmaceuticals in China
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Macroeconomic Indicators
6.1. Country data

7 Pharmaceuticals in India
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8 Macroeconomic Indicators
8.1. Country data

9 Pharmaceuticals in Russia
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis

10 Macroeconomic Indicators
10.1. Country data

11 Company Profiles
11.1. Ache Laboratorios Farmaceuticos SA
11.2. Hypera SA
11.3. EMS Sigma Pharma
11.4. Yangtze River Pharmaceutical Group
11.5. Shanghai Pharmaceuticals Holding Co Ltd
11.6. Yunnan Baiyao Group Co Ltd
11.7. Guangzhou Pharmaceutical Holdings Ltd
11.8. Sun Pharmaceutical Industries Ltd
11.9. Lupin Ltd
11.10. Aurobindo Pharma Ltd
11.11. Dr. Reddy's Laboratories Limited
11.12. Sanofi SA
11.13. Bayer AG
11.14. Novartis AG
11.15. Les Laboratoires Servier

12 Appendix
12.1. Methodology
12.2. About MarketLine

List of Tables
Table 1: BRIC pharmaceuticals industry, revenue($bn), 2017-26
Table 2: BRIC pharmaceuticals industry, revenue($bn), 2017-21
Table 3: BRIC pharmaceuticals industry, revenue($bn), 2021-26
Table 4: Brazil pharmaceuticals market value: $ billion, 2016-21
Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2021
Table 6: Brazil pharmaceuticals market share: % share, by value, 2021
Table 7: Brazil pharmaceuticals market value forecast: $ billion, 2021-26
Table 8: Brazil size of population (million), 2017-21
Table 9: Brazil gdp (constant 2005 prices, $ billion), 2017-21
Table 10: Brazil gdp (current prices, $ billion), 2017-21
Table 11: Brazil inflation, 2017-21
Table 12: Brazil consumer price index (absolute), 2017-21
Table 13: Brazil exchange rate, 2017-21
Table 14: China pharmaceuticals market value: $ billion, 2016-21
Table 15: China pharmaceuticals market geography segmentation: $ billion, 2021
Table 16: China pharmaceuticals market share: % share, by value, 2021
Table 17: China pharmaceuticals market value forecast: $ billion, 2021-26
Table 18: China size of population (million), 2017-21
Table 19: China gdp (constant 2005 prices, $ billion), 2017-21
Table 20: China gdp (current prices, $ billion), 2017-21
Table 21: China inflation, 2017-21
Table 22: China consumer price index (absolute), 2017-21
Table 23: China exchange rate, 2017-21
Table 24: India pharmaceuticals market value: $ billion, 2016-21
Table 25: India pharmaceuticals market geography segmentation: $ billion, 2021
Table 26: India pharmaceuticals market share: % share, by value, 2021
Table 27: India pharmaceuticals market value forecast: $ billion, 2021-26
Table 28: India size of population (million), 2017-21
Table 29: India gdp (constant 2005 prices, $ billion), 2017-21
Table 30: India gdp (current prices, $ billion), 2017-21
Table 31: India inflation, 2017-21
Table 32: India consumer price index (absolute), 2017-21
Table 33: India exchange rate, 2017-21
Table 34: Russia pharmaceuticals market value: $ billion, 2016-21
Table 35: Russia pharmaceuticals market geography segmentation: $ billion, 2021
Table 36: Russia pharmaceuticals market share: % share, by value, 2021
Table 37: Russia pharmaceuticals market value forecast: $ billion, 2021-26
Table 38: Russia size of population (million), 2017-21
Table 39: Russia gdp (constant 2005 prices, $ billion), 2017-21
Table 40: Russia gdp (current prices, $ billion), 2017-21
Table 41: Russia inflation, 2017-21
Table 42: Russia consumer price index (absolute), 2017-21
Table 43: Russia exchange rate, 2017-21
Table 44: Ache Laboratorios Farmaceuticos SA: key facts
Table 45: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 46: Hypera SA: key facts
Table 47: Hypera SA: Annual Financial Ratios
Table 48: Hypera SA: Key Employees
Table 49: EMS Sigma Pharma: key facts
Table 50: EMS Sigma Pharma: Key Employees
Table 51: Yangtze River Pharmaceutical Group: key facts
Table 52: Yangtze River Pharmaceutical Group: Key Employees
Table 53: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 54: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 55: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 56: Yunnan Baiyao Group Co Ltd: key facts
Table 57: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios
Table 58: Yunnan Baiyao Group Co Ltd: Key Employees
Table 59: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 60: Guangzhou Pharmaceutical Holdings Ltd: Key Employees
Table 61: Sun Pharmaceutical Industries Ltd: key facts
Table 62: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 63: Sun Pharmaceutical Industries Ltd: Key Employees
Table 64: Lupin Ltd: key facts
Table 65: Lupin Ltd: Annual Financial Ratios
Table 66: Lupin Ltd: Key Employees
Table 67: Lupin Ltd: Key Employees Continued
Table 68: Aurobindo Pharma Ltd: key facts
Table 69: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 70: Aurobindo Pharma Ltd: Key Employees
Table 71: Dr. Reddy's Laboratories Limited: key facts
Table 72: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 73: Dr. Reddy's Laboratories Limited: Key Employees
Table 74: Sanofi SA: key facts
Table 75: Sanofi SA: Annual Financial Ratios
Table 76: Sanofi SA: Key Employees
Table 77: Sanofi SA: Key Employees Continued
Table 78: Bayer AG: key facts
Table 79: Bayer AG: Annual Financial Ratios
Table 80: Bayer AG: Key Employees
Table 81: Bayer AG: Key Employees Continued
Table 82: Novartis AG: key facts
Table 83: Novartis AG: Annual Financial Ratios
Table 84: Novartis AG: Key Employees
Table 85: Novartis AG: Key Employees Continued
Table 86: Les Laboratoires Servier: key facts
Table 87: Les Laboratoires Servier: Key Employees

List of Figures
Figure 1: BRIC pharmaceuticals industry, revenue($bn), 2017-26
Figure 2: BRIC pharmaceuticals industry, revenue($bn), 2017-21
Figure 3: BRIC pharmaceuticals industry, revenue($bn), 2021-26
Figure 4: Brazil pharmaceuticals market value: $ billion, 2016-21
Figure 5: Brazil pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 6: Brazil pharmaceuticals market share: % share, by value, 2021
Figure 7: Brazil pharmaceuticals market value forecast: $ billion, 2021-26
Figure 8: Forces driving competition in the pharmaceuticals market in Brazil, 2021
Figure 9: Drivers of buyer power in the pharmaceuticals market in Brazil, 2021
Figure 10: Drivers of supplier power in the pharmaceuticals market in Brazil, 2021
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2021
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2021
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2021
Figure 14: China pharmaceuticals market value: $ billion, 2016-21
Figure 15: China pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 16: China pharmaceuticals market share: % share, by value, 2021
Figure 17: China pharmaceuticals market value forecast: $ billion, 2021-26
Figure 18: Forces driving competition in the pharmaceuticals market in China, 2021
Figure 19: Drivers of buyer power in the pharmaceuticals market in China, 2021
Figure 20: Drivers of supplier power in the pharmaceuticals market in China, 2021
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2021
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2021
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in China, 2021
Figure 24: India pharmaceuticals market value: $ billion, 2016-21
Figure 25: India pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 26: India pharmaceuticals market share: % share, by value, 2021
Figure 27: India pharmaceuticals market value forecast: $ billion, 2021-26
Figure 28: Forces driving competition in the pharmaceuticals market in India, 2021
Figure 29: Drivers of buyer power in the pharmaceuticals market in India, 2021
Figure 30: Drivers of supplier power in the pharmaceuticals market in India, 2021
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2021
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2021
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in India, 2021
Figure 34: Russia pharmaceuticals market value: $ billion, 2016-21
Figure 35: Russia pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 36: Russia pharmaceuticals market share: % share, by value, 2021
Figure 37: Russia pharmaceuticals market value forecast: $ billion, 2021-26
Figure 38: Forces driving competition in the pharmaceuticals market in Russia, 2021
Figure 39: Drivers of buyer power in the pharmaceuticals market in Russia, 2021
Figure 40: Drivers of supplier power in the pharmaceuticals market in Russia, 2021
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2021
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2021
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2021